Gene therapy
News
28 June 2021
Preliminary results of clinical trial for rare liver disease Crigler-Najjar syndrome presented at EASL congress
(plus)
23 April 2021
Genethon announces First Patient dosed in Clinical Trial of Investigational Gene therapy GNT 0004 for Duchenne Muscular Dystrophy
(plus)
28 February 2021
Genethon, 30 years of pioneering research and innovation in treating rare diseases
(plus)
10 February 2021
Genethon and WhiteLab Genomics join forces to enhance gene therapy through artificial intelligence
(plus)
3 February 2021
Genethon is delighted about the launch of a gene therapy clinical trial for late-onset Pompe disease
(plus)
2 December 2020
Genethon gets the green light from the ANSM to start an innovative gene therapy trial for Duchenne muscular dystrophy
(plus)
21 September 2020
Genethon welcomes the submission to EMA of Marketing Authorisation Application for LUMEVOQ® Gene Therapy to Treat Vision Loss due to Leber Hereditary Optic Neuropathy (LHON)
(plus)
10 June 2020
A Genethon team succeeds in inhibiting the immune response linked to AAV, opening up the possibility of treating more patients by gene therapy
(plus)
30 January 2020
Genethon welcomes the conclusive results of a gene therapy trial in Chronic Septic Granulomatosis, a rare disease of the immune system
(plus)
9 January 2020
Genethon strengthens its collaboration with Sarepta Therapeutics for the development of the gene therapy product GNT0004 in Duchenne muscular dystrophy
(plus)
9 September 2019
A gene therapy based clinical trial for Fanconi anemia patients offers its first successful results
(plus)
26 June 2019
First in vivo proof-of-concept in Steinert’s myotonic dystrophy, a neuromuscular disease
(plus)
24 May 2019
Towards a clinical trial for gamma-sarcoglycanopathy, limb-girdle muscular dystrophy
(plus)
5 October 2018
Co-administration of AAV Vectors with SVP-Rapamycin Enables Vector Re-administration in Pre-clinical Gene Therapy Study Published in Nature Communications by Généthon and Selecta Biosciences
(plus)
12 February 2018
Genethon starts a clinical trial to test a gene therapy treatment for a rare liver disease, Crigler-Najjar Syndrome
(plus)
15 December 2017
A gene therapy alliance in X-linked chronic granulomatous disease with Orchard Therapeutics
(plus)
Our science
Acting for the general interest
Our mission: Conception, clinic and preclinic development of drugs of genic therapy for rare illness.
Our goal: Providing these innovative treatments to the sick.
